Latest Breaking News On - Acrux pharmaceuticals - Page 1 : comparemela.com

Phase 2 Trial Data Show That Novel Antibiotic Led to 96% Cure Rate for C diff Infection

Iberzaplstat was non-inferior to standard of care vancomycin, was safe and tolerable, and will advance into a phase 3 trial.

United statesJo panuwatStuart johnsonRobertj delucciaKevin gareyAcrux pharmaceuticalsUniversity of houston college pharmacyUs centers for diseaseLoyola universityAcurx scientific advisory boardHouston collegeDisease controlAwareness month

Global Biotechnology Services Market Report 2021: Market is Expected to Grow at a CAGR of 10 0% from 2025 and Reach $218,924 7 Million in 2030

Global Biotechnology Services Market Report 2021: Market is Expected to Grow at a CAGR of 10 0% from 2025 and Reach $218,924 7 Million in 2030
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesMayne pharmaAryogen pharmedXmoor pharmaApsen farmaceuticaAsia pacificPierre fabreDaiichi sankyoArtios pharmaSanofi genzymeAspen pharmacareEppendorf asia pacific sdnLaboratorios legrandCstone pharmCambridge bioscienceBiosun pharmed